This online piece – and the slickly produced video within it – were apparently done for CNN International and a segment called “Make, Create, Innovate.” We suggest, instead, an approach that would discuss “Data, Evidence, Costs” and more.
Aided by caveats in a concluding quote from an independent expert, this story was appropriately cautious about the value of an experimental approach for children at risk of autism. But it should have warned readers that the findings were not statistically significant. We offer training to help journalists make these judgments.
Meeting most of our criteria for quality health journalism, this solid Wall Street Journal “Aches and Claims” column helps readers sort out research on a potential cholesterol-lowing supplement.
This is the second Medical News Today story that we’ve reviewed in as many weeks that relies almost entirely on a news release. We hope that’s not the start of a pattern.
This insightful piece explores the cost-benefit tradeoffs of Mohs surgery — a procedure that involves excising cancerous skin tumors and immediately examining them with a microscope to confirm that the entire tumor is removed. But it’s a bit one-sided: the story does not address the harms and limitations of the procedure. And the cost issues raised by the story are not as thoroughly explored as we’d have liked.
Tackling a very interesting topic — weight regain after bariatric surgery — this story could’ve used a bit more scrutiny of the evidence that underlies the claims.
This story was strong in explaining how a new, surgically implanted weight loss device is thought to work. But it didn’t caution readers about potential harms of the procedure — a significant omission.
This story asks if a cup of blueberries can keep the doctor away. The answer should have been much clearer.
A few modest additions would have made this 3-star effort much more useful for readers.
We applaud the clear effort to solicit several different independent expert perspectives – a strong point with this story.